| Literature DB >> 32450131 |
Dae Hyun Ha1, Sun-Don Kim2, Joon Lee3, Hyuck Hoon Kwon4, Gyeong-Hun Park5, Steve Hoseong Yang6, Jae Yoon Jung4, Jun Ho Lee1, Sang Rae Park1, Jinkwon Youn1, Sang Hee Lee1, Ji Eun Kim1, Jihye Lim1, Hyun-Kul Lee2, Byong Seung Cho7, Yong Weon Yi8.
Abstract
Several studies report that the therapeutic mechanism of action of mesenchymal stem/stromal cells (MSCs) is mainly mediated by paracrine factors that are released from MSCs such as exosomes. Exosomes are nano-sized extracellular vesicles that are transferred to target cells for cell-to-cell communication. Although MSC-derived exosomes (MSC-exosomes) are suggested as novel cell-free therapeutics for various human diseases, evaluation studies for the safety and toxicity of MSC-exosomes are limited. The purpose of our study was to evaluate the toxicological profile, including skin sensitization, photosensitization, eye and skin irritation, and acute oral toxicity using exosomes derived from human adipose tissue-derived MSCs (ASC-exosomes) in accordance with the OECD guidelines and the principles of Good Laboratory Practice. The ASC-exosomes were classified as a potential non-sensitizer in the skin sensitization test, UN GHS no category in the eye irritation test, and as a skin non-irritant in the skin irritation test, and did not induce any toxicity in the phototoxicity test or in acute oral toxicity testing. Our findings are the first to suggest that ASC-exosomes are safe for use as a topical treatment, with no adverse effects in toxicological testing, and have potential application as a therapeutic agent, cosmetic ingredient, or for other biological uses.Entities:
Keywords: Adipose tissue-derived mesenchymal stem cells (ASCs); Exosomes; Safety; Skin; Toxicology
Mesh:
Year: 2020 PMID: 32450131 DOI: 10.1016/j.yrtph.2020.104686
Source DB: PubMed Journal: Regul Toxicol Pharmacol ISSN: 0273-2300 Impact factor: 3.271